Skip to content
value.today

BeOne Medicines Ltd. vs UCB SA

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • UCB SA is the larger company by market value: $48.6 B against $42.6 B for BeOne Medicines Ltd., 1.1 times as much (market caps of Aug 1, 2026). BeOne Medicines Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. UCB SA's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • UCB SA had more revenue: $9.2 B in the year to December 2025 against $1.4 B for BeOne Medicines Ltd. in the year to December 2022.
  • UCB SA made a net profit of $1.8 B, while BeOne Medicines Ltd. made a net loss of $2.0 B.
  • UCB SA keeps more of each dollar of sales: a net margin of 20.1% against -141.6% for BeOne Medicines Ltd.
  • BeOne Medicines Ltd. employs more people: 9,200 against 8,703 at UCB SA. Each employee brings in about $153,804 of revenue at BeOne Medicines Ltd. and $1,054,865 at UCB SA.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01032063094122020202120222023202420252026BeOne Medicines Ltd. 412UCB SA 323

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$2B$4B$7B$9B20242025UCB SA $9B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBeOne Medicines Ltd.
ONC · #608 in the world
UCB SA
UCB.BR · #519 in the world
Profile
Country🇰🇾 Cayman Islands🇧🇪 Belgium
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20101928
Size
Market cap$42.6 B$48.6 B
Revenue$1.4 B$9.2 B
Net income$-2.0 B$1.8 B▲ best
Employees9,2008,703
Valuation
P/E ratio—26.3×
Price to sales30.1×5.3×
Price to book9.7×3.8×
Free cash flow yield—2.3%
Profitability
Net margin—20.1%
Return on equity—15.2%
Growth
Revenue growth—31.1%
Altman Z-score zone——
Data as ofMarket cap Aug 2026Market cap Aug 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, BeOne Medicines Ltd. or UCB SA?

UCB SA is the larger company by market value: $48.6 B against $42.6 B for BeOne Medicines Ltd., 1.1 times as much (market caps of Aug 1, 2026). BeOne Medicines Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. UCB SA's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, BeOne Medicines Ltd. or UCB SA?

UCB SA had more revenue: $9.2 B in the year to December 2025 against $1.4 B for BeOne Medicines Ltd. in the year to December 2022. UCB SA made a net profit of $1.8 B, while BeOne Medicines Ltd. made a net loss of $2.0 B.

Which is more profitable, BeOne Medicines Ltd. or UCB SA?

UCB SA keeps more of each dollar of sales: a net margin of 20.1% against -141.6% for BeOne Medicines Ltd.

Which has more employees, BeOne Medicines Ltd. or UCB SA?

BeOne Medicines Ltd. employs more people: 9,200 against 8,703 at UCB SA. Each employee brings in about $153,804 of revenue at BeOne Medicines Ltd. and $1,054,865 at UCB SA.

Sources#

Every figure on this page comes from these, with the date shown next to it.